Awarded
LUV00996 The provision of services for formulation development, clinical batch manufacture and distribution of the active pharmaceutical ingredient (API), Resveratrol: the COLO-PREVENT study
Descriptions
LUV00996 The provision of services for formulation development, clinical batch manufacture and distribution of the active pharmaceutical ingredient (API), Resveratrol: the COLO-PREVENT study. COLO-PREVENT will assess whether intervention with the API resveratrol is able to affect recurrence of colorectal adenomas within the NHS Bowel Cancer Screening Programme., Award of contract is dependent on: a)prior receipt by the University of an award letter from the funder (CRUK) and b) a cap on the overall budget of £1,268,920 including VAT at 20%.
Timeline
Published Date :
Deadline :
Tender Awarded :
Awarded date :
Contract Start :
Contract End :
Tender Regions
CPV Codes
Workflows
Status :
Assign to :
Tender Progress :
Details
Notice Type :
Tender Identifier :
TenderBase ID :
Low Value :
High Value :
Region :
Attachments :
Buyer Information
Address :
Website :
Procurement Contact
Name :
Designation :
Phone :
Email :
Possible Competitors
1 Possible Competitors
